Literature DB >> 7988628

No influence of ciprofloxacin on ethanol disposition. A pharmacokinetic-pharmacodynamic interaction study.

F Kamali1.   

Abstract

The influence of pretreatment with a three day course of ciprofloxacin (500 mg twice daily) on a single oral dose of ethanol (30 g) was investigated in 12 healthy male volunteers in a double blind placebo controlled study. Pretreatment with ciprofloxacin was shown to have no significant effect on ethanol AUC (736 mg.l-1 h placebo; 734 mg.l-1 h ciprofloxacin), Cmax (466 mg.l-1 placebo; 483 mg.l-1 ciprofloxacin) tmax (0.6 h placebo; 0.5 h ciprofloxacin) or the elimination rate (134 mg.l-1 h-1 placebo; 133 mg.l-1 h-1 ciprofloxacin). The effect of ciprofloxacin on ethanol pharmacodynamics was measured by the use of psychomotor tests, such as the critical flicker fusion threshold, choice reaction time, pursuit rotor, tapping rate, digit symbol substitution and digit span. Subjective feelings of concentration, vigilance and relaxation were also measured using visual analogue scales. Pretreatment with ciprofloxacin was found to have no significant effect on any of these tests, compared to placebo.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7988628     DOI: 10.1007/BF00193482

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  15 in total

1.  Effects of low concentrations of ethanol on the fluidity of spin-labeled erythrocyte and brain membranes.

Authors:  J H Chin; D B Goldstein
Journal:  Mol Pharmacol       Date:  1977-05       Impact factor: 4.436

2.  Gyrase-inhibitors impair caffeine elimination in man.

Authors:  A H Staib; S Harder; S Mieke; C Beer; W Stille; P Shah
Journal:  Methods Find Exp Clin Pharmacol       Date:  1987-03

3.  Effect of ciprofloxacin on the pharmacokinetics of antipyrine in healthy volunteers.

Authors:  K K Tan; M C Allwood; S Shawket
Journal:  J Clin Pharm Ther       Date:  1990-04       Impact factor: 2.512

4.  Ethanol and the physical properties of brain membranes: fluorescence studies.

Authors:  R A Harris; F Schroeder
Journal:  Mol Pharmacol       Date:  1981-07       Impact factor: 4.436

Review 5.  Drugs, alcohol and driving.

Authors:  T Seppala; M Linnoila; M J Mattila
Journal:  Drugs       Date:  1979-05       Impact factor: 9.546

6.  Observations on interpretation of blood alcohol levels derived from analysis of urine.

Authors:  J P Payne; D V Foster; D W Hill; D G Wood
Journal:  Br Med J       Date:  1967-09-30

7.  The influence of quinolone derivatives on theophylline clearance.

Authors:  W J Wijnands; T B Vree; C L van Herwaarden
Journal:  Br J Clin Pharmacol       Date:  1986-12       Impact factor: 4.335

8.  Anxiety and sleep after fosazepam.

Authors:  S Allen; I Oswald
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335

9.  Quinolones, theophylline, and diclofenac interactions with the gamma-aminobutyric acid receptor.

Authors:  S Segev; M Rehavi; E Rubinstein
Journal:  Antimicrob Agents Chemother       Date:  1988-11       Impact factor: 5.191

10.  Inhibitory effects of quinolone antibacterial agents on gamma-aminobutyric acid binding to receptor sites in rat brain membranes.

Authors:  A Tsuji; H Sato; Y Kume; I Tamai; E Okezaki; O Nagata; H Kato
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

View more
  2 in total

Review 1.  Pharmacokinetic and pharmacodynamic drug interactions with ethanol (alcohol).

Authors:  Lingtak-Neander Chan; Gail D Anderson
Journal:  Clin Pharmacokinet       Date:  2014-12       Impact factor: 6.447

2.  Ciprofloxacin decreases the rate of ethanol elimination in humans.

Authors:  J Tillonen; N Homann; M Rautio; H Jousimies-Somer; M Salaspuro
Journal:  Gut       Date:  1999-03       Impact factor: 23.059

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.